Monomethyl auristatin E intermediate-9

• UNSPSC Description:

  Monomethyl auristatin E intermediate-9 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs)[1].

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Cancer-programmed cell death

• Field of Research:

  cancer

• Assay Protocol:

  https://www.medchemexpress.com/monomethyl-auristatin-e-intermediate-9.html

• Purity:

  98.75

• Solubility:

  10 mM in DMSO

• Smiles:

  CC[C@H](C)[C@@H]([C@@H](CC(OC(C)(C)C)=O)OC)N(C(OCC1=CC=CC=C1)=O)C

• Molecular Weight:

  393.52

• References & Citations:

  [1]Lisa Buckel, et al. Tumor radiosensitization by monomethyl auristatin E: mechanism of action and targeted delivery. Cancer Res. 2015 Apr 1;75(7):1376-87.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  No Development Reported

• CAS Number:

  120205-58-5